Solasia Pharma KK 4597.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 03/01/21 JST
166.00UNCH (UNCH)
52 week range
96.00 - 267.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close166.00
  • 52 Week High267.00
  • 52 Week High Date06/17/20
  • 52 Week Low96.00
  • 52 Week Low Date03/13/20
  • Market Cap208.66M
  • Shares Out122.64M
  • 10 Day Average Volume4.24M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change24.81

RATIOS/PROFITABILITY

  • EPS (TTM)-22.20
  • P/E (TTM)-7.48
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Solasia Pharma KK News

There is no recent news for this security.

Latest 4597.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System...
Yoshihiro Arai
President
Toshio Miyashita
Chief Financial Officer
Address
3F, Shiodome Bldg., 1-2-20, Kaigan
Minato-ku, TKY
105-0011
Japan